Publications

Click here to see Dr. Rizza's complete list of publications.

  1. Basu, R, Singh, Ravinder, J, Basu, A, Chittilapilly, E, Johnson, C, Toffolo, G, Cobelli, C, Rizza, R.. Splanchnic Cortisol Production Occurs in Humans: Evidence for Conversion of Cortisol to Cortisone Via the 11-ß Hydroxy Steroid Dehydrogenase (11-ß HSD) Type 1 Pathway. Diabetes 53:2051-2059, 2004.
  2. Basu, R., Basu, A., Johnson, C.M., Schwenk, W.F., Rizza, R.A. Insulin dose response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in non-diabetic humans and are abnormal in people with type 2 diabetes mellitus. Diabetes 53:2042-2050, 2004.
  3. Basu, R., Schwenk, W.F., Rizza, R.A.: Both fasting glucose production and disappearance both are abnormal in people with "mild" as well as "severe" type 2 diabetes. Am J Physiol Endocrinol Metab 287:E55-E62, 2004
  4. Reed, A.S., Charkoudian, N., Vella, A., Shah, P., Rizza, R.A., Joyner, M.J.: Forearm vascular control during acute hyperglycemia in healthy humans. Am J Physiol Endocrinol Metab 286:E472-E480, 2004.
  5. Ostergard, T., Carr, R.D., Thomsen, M.K., Gall, M., Rizza, R., Veldhuis, J.: The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency. J Clin Endocrinol Metab 89:297-302, 2004
  6. Adkins, A., Basu, R., Persson, M., Dicke, B., Shah, P., Vella, A., Schwenk, W.F., Rizza, R. Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in non-diabetic humans. Diabetes 52:2213-2220, 2003
  7. Zangeneh, F., Basu, R., Shah, P., Arora, P., Camilleri, M.; Rizza, R.: Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia. Am J Physiol Endocrinol Metab 285:E280-E286, 2003
  8. Short, K.R., Vittone, J.L., Bigelow, M.L., Proctor, D.N., Rizza, R.A., Coenen-Schimke, J.M., Nair, K.S.: Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 52:1888-1896, 2003.
  9. Basu, R., Breda,E., Oberg, A.L., Powell, C.C., Dalla Man, C., Basu, A., Vittone, J., Klee, G., Arora, P., Toffolo, G., Cobelli, C., Rizza, R.A.: Mechanisms of age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action and clearance. Diabetes 52:1738-1748, 2003
  10. Butler , A.E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R.A., Butler, P.C.: Beta-cell deficit and increased beta-cell apoptosis in humans with type-2 diabetes mellitus. Diabetes 52:102-110, 2003
  11. Shah, P., Vella, A., Basu, A., Basu, R., Adkins, A., Schwenk, W.F., Johnson, C.M., Nair, K.S., Jensen, M.D., Rizza, R.A.: Elevated free fatty acids impair glucose metabolism in women: decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia. Diabetes 52:38-42, 2003.
  12. Nielsen, M.F., Caumo, A., Chandramouli, V., Schumann, W. C., Cobelli, C., Landau, B. R., Rizza, R.A., Schmitz, O.: Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects. Am J Physiol Endocrinol Metab 286:E102-E110, 2004
  13. Rizza, R.A. , Vigersky, R.A., Rodbard, H.W., Ladenson, P.W., Young, W.F., Jr., Surks, M.S., Kahn, R., Hogan, P.F.: A model to determine workforce needs for endocrinologists until 2020. Endocr Pract 9(3):210-219, 2003.
  14. Rizza, R.A. , Vigersky, R.A., Rodbard, H.W., Ladenson, P.W., Young, W.F., Jr., Surks, M.S., Kahn, R., Hogan, P.F.: A model to determine workforce needs for endocrinologists until 2020. J Clin Endocrinol Metab 88(5):1979-1987, 2003.
  15. Rizza, R.A. , Vigersky, R.A., Rodbard, H.W., Ladenson, P.W., Young, W.F., Jr., Surks, M.S., Kahn, R., Hogan, P.F.: A model to determine workforce needs for endocrinologists until 2020. Diabetes Care 26(5):1545-1552, 2003.
  16. Vella, A., Reed, A.S., Charkoudian, N., Shah, P., Basu, R., Basu, A., Joyner, M.J., Rizza, R.A.: Glucose induced suppression of endogenous glucose production: dynamic response to differing glucose profiles. Am J Physiol Endocrinol Metab 285:E25-E30, 2003.
  17. Basu, R., Di Camillo, B., Toffolo, G., Basu, A., Shah, P., Vella, A., Rizza, R., Cobelli, C.: Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab 284:E55-E69, 2003.
  18. Vella, A., Shah, P., Reed, A.S., Adkins, A.S., Basu, R., Basu, A., Rizza, R.A.: Lack of effect of exendin-4 and glucagon-like peptide-1(7,36)-amide on insulin action in non-diabetic humans. Diabetologia 45:1410-1414, 2002
  19. Charkoudian, N., Vella, A., Reed, A.S., Minson, C.T., Shah, P., Rizza, R.A., Joyner, M.J.. Cutaneous vascular function during acute hyperglycemia in healthy young adults. J Appl Physiol 93:1243-1250, 2002.
  20. Vella, A., Shah, P., Basu, R., Basu, A., Camilleri, M., Schwenk, W.F., Rizza, R.A.: The effect of enteral versus parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans. Am J Physiol Endocrinol Metab 283:E259-E266, 2002.
  21. Halvatsiotis, P., Turk, D., Alzaid, A., Dinneen, S., Rizza, R.A., Nair, K.S.: Insulin effect on leucine kinetics in type II diabetes mellitus. Diab Nutr Metab 15:136-142, 2002.
  22. Gorman , C.A. , Zimmerman, B.R., Smith, S.A., Dinneen, S.F., Knudsen, J.B., Holm, D., Jorgensen, B., Bjornsen, S., Planet, K., Hanson, P., Rizza, R.A.: DEMS- A Second Generation (submitted).
  23. Vella, A., Lee, J.S., Camilleri, M.; Szarka, L.A., Burton, D.D., Zinsmeister, A.R., Rizza, R.A., Klein,P.D.: Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus. Neurogastroenterol Mot 14:123-131, 2002.
  24. Shah, P., Vella, A., Basu, A., Basu, R., Adkins, A., Schwenk, W.F., Johnson, C.M., Nair, K.S., Jensen, M.D., Rizza, R.A.: Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes 51:301-310, 2002.